• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B. BRAUN SURGICAL, S.A. OPTILENE 4/0 (1,5) 90CM 2XHR17 CV RCP; CARDIAC SUTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B. BRAUN SURGICAL, S.A. OPTILENE 4/0 (1,5) 90CM 2XHR17 CV RCP; CARDIAC SUTURE Back to Search Results
Model Number C3090902
Device Problems Material Frayed (1262); Material Integrity Problem (2978); Material Split, Cut or Torn (4008)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
It was reported an issue with optilene suture.The client reported that the suture become delaminated (and it should not) during the surgical procedure.No further information has been provided.
 
Manufacturer Narrative
Analysis and results: there are no previous complaints of this code-batch.We manufactured and distributed in the market (b)(4) units of this code-batch.There are no units in our stock.We have not received any sample for analysis.We have only received a picture showing a used thread with the thread damaged/splitted.However, without any closed sample we cannot carry out an analysis in order to take a decision.Reviewed the batch manufacturing record, this product had a normal process and the results during the process fulfill usp/ep and b.Braun surgical requirements.Remarks: when working with optilene® suture material, great care should be taken to avoid any crushing or crimping damage of the monofilament by instruments such as forceps or needle holders.Final conclusion: in spite of receiving a picture showing a defective sample, without closed samples a suitable analysis cannot be performed.Nevertheless, we take note of this incidence and if any closed sample is received in the future, we will re-open the case and analyse it.Actions on product distributed of this reference/batch: based on the conclusion derived from investigation, it is not required to make actions in distributed product.Corrective/preventive actions: according to our internal procedures, there is no need to establish corrective or preventive actions.Nevertheless, this complaint is recorded for trending analysis to assess if actions are needed in the future.
 
Manufacturer Narrative
Analysis and results: there are no previous complaints of this code-batch.We manufactured and distributed in the market (b)(4) units of this code-batch.There are no units in our stock.We have received three closed samples to analyze this complaint.We have tested the knot pull tensile strength of the samples received and the results fulfil the requirements of the european pharmacopoeia (ep): 1.38 kgf in average and 1.36 kgf in minimum (ep requirements: 0.51 kgf in average and 0.15 kgf in minimum) these values are the usual ones for this thread and size.Sewing test on artificial skin tissue has also been conducted with the three samples received and fraying/splitting does not appear when pulling the thread through the tissue.Visual appearance before and after performing the test is the usual one.Reviewed the batch manufacturing record, this product had a normal process and the results during the process fulfill usp/ep and b.Braun surgical requirements.Remarks: when working with optilene® suture material, great care should be taken to avoid any crushing or crimping damage of the monofilament by instruments such as forceps or needle holders.Final conclusion: although the results of the samples received fulfil the specifications of european pharmacopoeia/ b.Braun surgical specifications, we take note of this incidence in order to assess if new or additional actions are needed.Actions on product distributed of this reference/batch: based on the conclusion derived from investigation, it is not required to make actions in distributed product.Corrective/preventive actions: according to our internal procedures, there is no need to establish corrective or preventive actions.Nevertheless, this complaint is recorded for trending analysis to assess if actions are needed in the future.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTILENE 4/0 (1,5) 90CM 2XHR17 CV RCP
Type of Device
CARDIAC SUTURE
Manufacturer (Section D)
B. BRAUN SURGICAL, S.A.
carretera de terrassa 121
rubí, barcelona 08191
SP  08191
Manufacturer (Section G)
B. BRAUN SURGICAL, S.A.
carretera de terrassa 121
rubí, barcelona 08191
SP   08191
Manufacturer Contact
martina laporte
carretera de terrassa 121
rubí, barcelona 08191
SP   08191
MDR Report Key15864639
MDR Text Key307884251
Report Number3003639970-2022-00499
Device Sequence Number1
Product Code GAW
Combination Product (y/n)N
Reporter Country CodeHR
PMA/PMN Number
K133890
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/25/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberC3090902
Device Catalogue NumberC3090902
Device Lot Number122225
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/27/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-